Physician profile
Rick L Yoder
NPI 1528097938
$1,981.12
in general payments reported to CMS, 2019-2025
19 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $91.02 · 2022: $303 · 2023: $342 · 2024: $628 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,368.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $501.52 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $396.84 | 2022-2025 | Vraylar |
| Novo Nordisk INC | $204.80 | 2019-2025 | Wegovy |
| Exact Sciences Corporation | $189.22 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $106.40 | 2019-2023 | |
| Amgen INC. | $76.42 | 2019-2024 | Prolia, Evenity, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $73.41 | 2022 | |
| Lilly USA, LLC | $71.78 | 2022-2025 | Zepbound, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.29 | 2024-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $53.46 | 2019-2022 | |
| Inspire Medical Systems, INC. | $44.29 | 2024 | Inspire |
| Glaxosmithkline, LLC. | $37.66 | 2022-2023 | Arexvy, Shingrix, Bexsero |
| Sanofi-Aventis U.S. LLC | $35.00 | 2020 | |
| Amarin Pharma, INC. | $28.55 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $27.97 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $18.13 | 2022 | |
| Sonex Health, INC. | $17.48 | 2025 | Sx-One Microknife |
| E.R. Squibb & Sons, L.L.C. | $16.74 | 2019 | |
| Becton, Dickinson and Company | $16.16 | 2024 | Bd Max System, Bd Max Instrument |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rick Yoder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.